Weight management barriers and facilitators after breast cancer in Australian women: a national survey
»
Weight management barriers and facilitators after breast cancer in Australian women: a national survey
Background: Breast cancer is the most common cancer in women worldwide. weight gain after breast cancer is associated with poor health outcomes. The purpose of this study was to describe how the Australian breast cancer survivors now manage their weight.
Methods: The online survey of cross-sectional open to any woman living in Australia who identify themselves as having breast cancer, between November 2017 and January 2018. Results: We received 309 responses. Most respondents described their diet as good / excellent and the reported high levels of moderate-weight self-efficacy. Nonetheless, the proportion of overweight / obese increased from 47% at diagnosis to 67% at the time of the survey.
More than three-quarters of respondents did not receive advice on the prevention of weight gain at the time of diagnosis. 39% of women reported being less active after a diagnosis of cancer, and some weight loss interventions that are considered effective. Facilitator structured exercise program, proper diet, and accountability to others, while the often-cited barrier is lack of motivation / willingness, fatigue, and difficulty maintaining body weight. Women who cited fatigue as a barrier nearly two times more likely to commit low levels of physical activity (PA) or no PA than women who did not cite fatigue as a barrier.
Conclusion: We report a high level of concern about weight gain after SM and significant gaps in the provision of services around the prevention of weight gain and weight management. Women with BC should be provided with support for the prevention of weight gain in the initial survival phase, which should include a structured PA and dietary changes in combination with behavior change and social support. Weight loss or prevention of weight loss program must overcome obstacles such as fatigue. Further research is needed on the effectiveness of diet and exercise intervention on Survivor SM, especially with regard to the prevention of weight gain.
Weight management barriers and facilitators after breast cancer in Australian women: a national survey
Genomic Characterization of germline large complex rearrangements of BRCA1 and BRCA2 genes High Risk Breast Cancer Patients-Novel Variant of the National Center for Large
large genomic rearrangements (LGRs) that affects one or more exons of BRCA1 and BRCA2 are an important part of the spectrum of mutations in this gene. Since 2004, the National Institute of Oncology, Hungary, has been involved in screening for LGRs breast or ovarian cancer families registered for genetic testing. LGRs detected by the probe multiplex ligation amplification method, or next-generation sequencing. Where it is possible, transcript-level characterization LGRs do.
Phenotype data collected and analyzed as well. Altogether 28 species LGRs in 51 probands were detected. Sixteen LGRs new. Forty-nine cases are deletions or duplications in the BRCA1 and BRCA2 are two affected. Rearrangements accounted for 10% of BRCA1. Three exons copy of profit, two complex rearrangements, and 23 losses exons are marked by the determination of the appropriate breakpoint.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Rat Peripheral Blood Mononuclear Cell Isolation Kit
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
RT 6.1, Pta.A2 (RT6 T Lymphocyte Marker, Peripheral T Cells)
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Human Normal Peripheral Blood CD8+ Cytotoxic T Cells
Description: NPB-CD34+ stem/progenitor cells (NPB-CD34+) are positively isolated from mononuclear cells using an immunomagnetic CD34 MicroBead labeling system.
Description: Peripheral blood mononuclear cells are isolated from Sickle Cell Anemia (SCA) peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh SCA PBMCs is available upon request.
Human Normal Peripheral Blood CD8+/CD45RA+ Naive Cytotoxic T Cells
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays.
HighQC™ Human Mobilized Peripheral Blood CD34+ Stem Cell
Description: CD34 is a glycosylated transmembrane protein and represents a well-known marker for primitive blood-and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial stem cells. CD34+ stem cells are multipotent and can give rise to all cell types in hematopoietic system. Additionally, CD34 cells are responsible for all lymphohematopoietic lineages even though they comprise only a small portion of the cell population.Our Mobilized CD34+ cells (HSCs) are isolated from mobilized leuko paks using positive immunomagnetic cell separation procedures. All mobilized peripheral blood is collected in acid-citrate-dextrose formula A (ACDA) from fully consented IRB approved donors that have been mobilized with G-CSF (MPB).
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays. A peripheral blood mononuclear cell is defined as any blood cell with a round nucleus. These blood cells are a critical component in the immune system to fight infection and adapt to intruders. The lymphocyte population consists of CD4+ and CD8+ T cells, B cells and Natural Killer cells, CD14+ Monocytes, and Basophils/Neutrophils/Eosinophils/Dendritic cells. These cells are often extracted from whole blood or from leukopacks using ficoll, a hydrophilic polysaccharide that separates layers of blood, with monocytes and lymphocytes forming a buffy coat under a layer of plasma.Samples from each donor are tested via PCR to confirm non-reactivity.
Description: Peripheral blood mononuclear cells are isolated from Multiple Sclerosis (MS) peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh MS PBMCs is available upon request.
Description: Peripheral blood mononuclear cells are isolated from Osteoarthritis peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Osteoarthritis PBMCs is available upon request.
Description: Peripheral blood mononuclear cells are isolated from Rheumatoid Arthritis (RA) peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh RA PBMCs is available upon request.
Description: MPB-CD133+ Stem/Progenitor cells are positively isolated from MPB-Mononuclear Cells by using a direct immunomagnetic CD133 MicroBeads labeling system.
Description: Peripheral blood mononuclear cells are isolated from Systemic Lupus Erythematosus (SLE) peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh SLE PBMCs is available upon request.
Description: Clinical data may include: Medication (current and historical), Disease Severity, Smoking History, GOLD Stage, Spirometry, Lung function test (FEV, FVC, FEV1%), standard blood chemistry results.
Description: Gout is a form of inflammatory arthritis that develops in some people who have high levels of uric acid in the blood.andnbsp,Clinical data may include: Medication (current and historical), Disease severity, Uric acid levels.
Description: Acne is a chronic, inflammatory skin condition that causes spots and pimples, especially on the face, shoulders, back, neck, chest, and upper arms.
Description: <div Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. Clinical data may include: Medication (current and historical), Disease severity, Fatty infiltration levels</div.
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays. A peripheral blood mononuclear cell is defined as any blood cell with a round nucleus. These blood cells are a critical component in the immune system to fight infection and adapt to intruders. The lymphocyte population consists of CD4+ and CD8+ T cells, B cells and Natural Killer cells, CD14+ Monocytes, and Basophils/Neutrophils/Eosinophils/Dendritic cells. These cells are often extracted from whole blood or from leukopacks using ficoll, a hydrophilic polysaccharide that separates layers of blood, with monocytes and lymphocytes forming a buffy coat under a layer of plasma.Samples from each donor are tested via PCR to confirm non-reactivity.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Rat Peripheral myelin protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Untouched NPB-CD56+ Natural Killer (NK) cells are negatively isolated from mononuclear cells using an indirect immunomagnetic NK cell labeling system to deplete the non-CD56+ NK cells.
Description: Primary human immature dendritic cells (DCs) were derived from immunomagnetically selected peripheral blood (PB) monocytes. Monocytes were cultured in RPMI 1640 Medium with 10% fetal bovine serum (FBS), GM-CSF and IL-4 for 5 days to generate immature DCs. PB was collected using one of the following anticoagulants: acid-citrate-dextrose (ACD), acid-citrate-dextrose solution A (ACDA), citrate-phosphate-dextrose (CPD), citrate-phosphate-double-dextrose (CP2D), or citrate-phosphate-dextrose-adenine (CPDA).
Description: Vitiligo is a disease in which the pigment cells of the skin, melanocytes, are destroyed in certain areas.andnbsp,Clinical data may include: Medication (current and historical), Disease severity, VASI Score.
LGR concluded mechanism for the formation of mainly end-joining repair utilizes short homologies directly. Comparing the phenotypic features of LGR carriers to that of non-LGR carriers of BRCA1 mutation, revealed no significant differences. Our study is the largest comprehensive report LGRs of BRCA1 / 2 in familial breast and ovarian cancer patients in the region of Central and Eastern Europe. Our data add new insights to the interpretation genetically related to LGRs.
